For the Inventor, By the Inventor

Enter assignee name

Carlsbad, CA, United States of America

Ontogen Corporation

USPTO Granted Patents = 23

% Expired Patents = 4.3

Forward Citations = 625

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Romaine R Maiefski (12 out of 18 patents)

Adnan M Mjalli (10 out of 12 patents)

Sepehr Sarshar (5 out of 34 patents)

4. Don Wendell (5 out of 5 patents)

5. Jonathan D Krakover (4 out of 4 patents)

6. John Cargill (4 out of 9 patents)

7. Xiaodong Cao (4 out of 6 patents)

8. Farid Bakir (3 out of 15 patents)

9. Chengzhi Zhang (3 out of 60 patents)

10. Edmund J Moran (2 out of 48 patents)

11. William Charles Ripka (2 out of 27 patents)

12. Sepehar Sarshar (2 out of 2 patents)

13. Thomas James Baiga (1 out of 2 patents)

14. Robert W Armstrong (1 out of 3 patents)

15. Todd Kevin Jones (1 out of 110 patents)

23 patents: Sort by Forward Citations

1. 6528324 - Apparatus for pre-determined mass sorting of positional-encoded solid phase synthesis supports (2003-03-04),

2. 6508938 - Apparatus and method for multiple channel high throughput purification (2003-01-21),

3. 6458273 - Sample separation apparatus and method for multiple channel high throughput purification (2002-10-01),

4. 6416718 - Sample wash station assembly (2002-07-09),

5. 6388076 - Protein tyrosine phosphatase-inhibiting compounds (2002-05-14),

6. 6358414 - Pressure regulation apparatus and method for multiple channel high throughput purification (2002-03-19),

7. 6358413 - Microsampling apparatus and method for multiple channel high throughout purification (2002-03-19),

8. 6355164 - Sample collection apparatus and method for multiple channel high throughput purification (2002-03-12),

9. 6309541 - Apparatus and method for multiple channel high throughput purification (2001-10-30),

10. 6171555 - Reaction block docking station (2001-01-09),

11. 6107274 - Piperazines as inhibitors of fructose-1,6-bisphosphatase (FBPase) (2000-08-22),

12. 5976470 - Sample wash station assembly (1999-11-02),

13. 5965558 - Modulators of proteins with phosphotyrosine recognition units (1999-10-12),

14. 5866569 - Naphthalenedione nitric oxide synthase (NOS) inhibitors (1999-02-02),

15. 5840721 - Imidazole derivatives as MDR modulators (1998-11-24),

Company Overview

Ontogen Corporation, based in Carlsbad, California, specializes in the development of innovative biopharmaceuticals and therapeutic solutions. The company focuses on harnessing advanced technologies to create targeted treatments for various diseases, emphasizing the importance of precision medicine. With a commitment to research and development, Ontogen aims to address unmet medical needs through its cutting-edge approaches in drug discovery and development, contributing to the evolving landscape of healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

23 Patents

#56 in Carlsbad, CA

#3,421 in California

#14,438 in US

#27,714 in the World

Carlsbad, CA, United States of America

Ontogen Corporation

Forward Citations = 625

19 inventors:

Romaine R Maiefski (12 out of 18 patents)

Adnan M Mjalli (10 out of 12 patents)

Sepehr Sarshar (5 out of 34 patents)

4. Don Wendell (5 out of 5 patents)

5. Jonathan D Krakover (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ontogen Corporation. Retrieved from https://idiyas.com/company/ontogen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…